Source: Eur Respir J, 52 (1) 1800070; 10.1183/13993003.00070-2018
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Alessandro Mustazzolu, Emanuele Borroni, Daniela Maria Cirillo, Federico Giannoni, Angelo Iacobino, Lanfranco Fattorini. Trend in rifampicin-, multidrug- and extensively drug-resistant tuberculosis in Italy, 2009–2016. Eur Respir J, 52 (1) 1800070; 10.1183/13993003.00070-2018

Member's Comments

No comment yet.

Related content which might interest you: Treatment of TB Source: Eur Respir Mon 2012; 58: 154-166 Year: 2012 Transmission of multidrug-resistant and extensively drug-resistant tuberculosis in a metropolitan city Source: Eur Respir J 2013; 41: 901-908 Year: 2013 Alarming levels of drug-resistant tuberculosis in Belarus: results of a survey in Minsk Source: Eur Respir J 2012; 39: 1425-1431 Year: 2012 Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis Source: Eur Respir J 2016; 47: 564-574 Year: 2016 Early access to bedaquiline for extensively drug-resistant (XDR) and pre-XDR tuberculosis Source: Eur Respir J, 54 (1) 1802208; 10.1183/13993003.02208-2018 Year: 2019 Laboratory system to detect multidrug-resistant (MDR) and extensively drug-resistant (XDR) mycobacterium tuberculosis strains in clinical practice Source: Annual Congress 2008 - Epidemiological and clinical aspects of tuberculosis control Year: 2008 Multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis: epidemiology, diagnosis and treatment Source: Annual Congress 2008 - Infection year in review Year: 2008 Epidemiology of TB Source: Eur Respir Mon 2012; 58: 14-25 Year: 2012 Treating extensively drug resistant tuberculosis (XDR-TB) in India Source: Annual Congress 2008 - Epidemiology and clinical management of multidrug-resistant and extensively drug-resistant tuberculosis Year: 2008 A case of resistance beyond extensively drug-resistant tuberculosis in Japan Source: Eur Respir J 2013; 42: 870-872 Year: 2013 A case of resistance beyond extensively drug-resistant tuberculosis in Japan Source: Eur Respir J 2013; 42: 872-873 Year: 2013 Clinical and operational value of the extensively drug-resistant tuberculosis definition Source: Eur Respir J 2007; 30: 623-626 Year: 2007 Risk factors for multidrug-resistant and extensively drug-resistant tuberculosis in Estonia Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis Year: 2008 Molecular surveillance of multi-drug resistant tuberculosis in Europe Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis Year: 2007 Genotypes and drug resistance patterns of multi-drug-resistant mycobacterium tuberculosis strains in Pakistan Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology Year: 2015 Extensively drug-resistant tuberculosis (XDR-TB) and multidrug-resistant tuberculosis (MDR-TB): a retrospective comparative study Source: Annual Congress 2008 - Multidrug-resistant and the emerging threat of extensively drug-resistant tuberculosis Year: 2008 Multidrug- and extensively drug-resistant tuberculosis: an emerging threat Source: Eur Respir Rev 2009; 18: 195-197 Year: 2009 Resistance to second-line injectables and treatment outcomes in multidrug-resistant and extensively drug-resistant tuberculosis cases Source: Eur Respir J 2008; 31: 1155-1159 Year: 2008 Adjunctive resectional lung surgery for extensively drug-resistant tuberculosis Source: Eur Respir J 2009; 34: 180-183 Year: 2009 Risk of mortality of extensively drug-resistant tuberculosis (XDR-TB) in Italy and Germany Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis Year: 2007